This trialis testing if a new type of pill can end a pregnancy. Participants take a pill at the clinic, and then take it daily for 6 more days, then return to the clinic and take another pill. Follow-up visits include an ultrasound to check if the abortion was successful.
1 Primary · 0 Secondary · Reporting Duration: Within 7 days of initiating atorvastatin (80 mg per day)
1 Treatment Group
Experimental: Atorvastatin followed by misoprostol
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: Experimental: Atorvastatin followed by misoprostol · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18 - 50 · Female Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this experiment accommodating elderly individuals?
"Eligibility for this study necessitates that participants be aged 18 or older, and under 50 years of age." - Anonymous Online Contributor
Is the recruitment for this clinical experiment still open?
"Per the details on clinicaltrials.gov, this research is currently enrolling participants. It was initially posted in April of 2022 and its data was most recently updated at the end of October that same year." - Anonymous Online Contributor
What type of participants are most suitable for this research?
"This clinical trial seeks 30 individuals aged between 18 and 50 who have experienced an early abortion. The prospective participants must be able to speak English or Spanish, willing to postpone their termination of pregnancy by up to two weeks, abstain from contraception until the completion of their abortion procedure, comply with all protocol requirements, and accept that they may require a uterine aspiration in order for the study regimen to successfully terminate their pregnancy." - Anonymous Online Contributor
How many participants are currently included in this research endeavor?
"Affirmative, clinicaltrials.gov verifies that this trial is currently seeking participants. The study was first published on April 19th 2022 and has recently been edited on October 28th 2022. 30 individuals are required from 1 medical centre for the experiment to commence." - Anonymous Online Contributor